SCHEMBL18734959

SCHEMBL18734959

CCC(=O)NC(C(=O)N(CC)CC)C(C)SC(=O)C(=O)CC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18734963 0.90 — —
SCHEMBL18734952 0.90 MGAM (0.33) —
SCHEMBL18735174 0.87 — —
SCHEMBL18734972 0.85 — —
SCHEMBL18735371 0.82 L3MBTL1 (0.35) —
SCHEMBL18734948 0.80 — —
SCHEMBL18734958 0.78 MGAM (0.33) —
SCHEMBL18734971 0.78 — —
SCHEMBL18735191 0.77 GAA (0.35) —
SCHEMBL18735146 0.77 LMNA (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback